hrp0089p1-p155 | GH & IGFs P1 | ESPE2018
Lutski Miri
, Zuker Inbar
, Libruder Carmit
, Blumenfeld Orit
, Zadik Zvi
, Shohat Tamy
, Laron Zvi
Background: Growth hormone (GH) is a diabetogenic hormone.Objective: To determine the long term risk for diabetes in a cohort of children treated with recombinant human (rhGH) in Israel, using data from the Israeli National Diabetes Register (INDR) for 2014 as a reference.Methods and patients: Between the years 1988 and 2009, 2,513 children under the age of 19 were approved for GH treatment. The patients were categorized to a low-r...